2166 studies found for:    Mexico
Show Display Options
Rank Status Study
1 Active, not recruiting Open-label Follow up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Aged 16 Years or Older Suffering From Epilepsy.
Condition: Epilepsy
Intervention: Drug: Brivaracetam
2 Completed
Has Results
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
3 Terminated
Has Results
(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Ambrisentan;   Drug: Placebo
4 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
5 Active, not recruiting Moxifloxacin in Pediatric Subjects With Complicated Intra-abdominal Infection
Condition: Intraabdominal Infections
Interventions: Drug: Moxifloxacin (Avelox, BAY12-8039);   Drug: Ertapenem, Amoxicillin/clavulanate
6 Recruiting Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Condition: Acute Depressive Episode
Interventions: Drug: Ramelteon SL;   Drug: Placebo
7 Recruiting MAESTRO-OL: Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity (Open-Label)
Condition: Eisenmenger Syndrome
Intervention: Drug: Macitentan 10 mg tablet, once daily.
8 Recruiting Safety and Efficacy of Extended Treatment With Secukinumab in Anti-TNF Inadequate Responders in RA.
Condition: Rheumatoid Arthritis
Intervention: Biological: Secukinumab (AIN457)
9 Completed
Has Results
Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Conditions: Breast Cancer;   Metastases
Interventions: Drug: Ixabepilone + Capecitabine;   Drug: Capecitabine
10 Completed Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study
Condition: NSCLC
Intervention: Drug: Gefitinib
11 Completed A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: taspoglutide;   Drug: Placebo
12 Completed
Has Results
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
Condition: Venous Thrombosis
Interventions: Drug: Enoxaparin;   Drug: warfarin;   Drug: Placebo for apixaban;   Drug: Placebo for enoxaparin;   Drug: Placebo for warfarin;   Drug: apixaban
13 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
14 Recruiting GLORIA-AF Registry Program - Second and Third Phases
Conditions: Stroke;   Atrial Fibrillation
Intervention:
15 Recruiting MAESTRO (Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity)
Condition: Eisenmenger Syndrome
Interventions: Drug: Macitentan 10 mg, oral tablet, to be taken once daily.;   Drug: Matching placebo oral tablet, to be taken once daily.
16 Completed A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Drug: Certolizumab Pegol
17 Completed A Phase II Study on Immunogenicity and Safety of MVA-BN® (IMVAMUNE™) Smallpox Vaccine in Subjects With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Biological: MVA-BN® (IMVAMUNE);   Biological: IMVAMUNE
18 Completed PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
19 Completed
Has Results
Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
Conditions: Venous Thrombosis;   Pulmonary Embolism
Interventions: Drug: Apixaban;   Drug: Enoxaparin
20 Completed
Has Results
Phase IIIB Switching From Intravenous to Subcutaneous Study
Condition: Arthritis, Rheumatoid
Intervention: Drug: Abatacept

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years